Accelerating HTP Stable Expression of Complex Biologics
Posted on February 24, 2025
Whitney Liu, Ph.D., Principal Scientist, Discovery Biotherapeutics Department, Bristol Myers Squibb
Summary Chinese hamster ovary (CHO) cells are the major mammalian expression systems for producing biotherapeutics, with advantages in facilitating proper protein folding, assembly and post-translational modifications, alongside high yield and stable cell line supply. The traditional CHO cell line d...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
